Vabicaserin API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Vabicaserin API 887258-95-9?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Vabicaserin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Vabicaserin
- Synonyms:
- Cas Number:
- 887258-95-9
- DrugBank number:
- DB12071
- Unique Ingredient Identifier:
- WD9550HPNL
General Description:
Vabicaserin, identified by CAS number 887258-95-9, is a notable compound with significant therapeutic applications. Vabicaserin has been used in trials studying the health services research and treatment of Schizophrenia.
Classification:
Vabicaserin belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine, classified under the direct parent group 1,4-benzodiazepines. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Benzodiazepines class, specifically within the 1,4-benzodiazepines subclass.
Categories:
Vabicaserin is categorized under the following therapeutic classes: Antidepressive Agents, Central Nervous System Depressants, Heterocyclic Compounds, Fused-Ring, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 5-HT2 Receptor Agonists, Serotonin 5-HT2C Receptor Agonists, Serotonin Agents, Serotonin Receptor Agonists. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Vabicaserin is a type of Benzodiazepines
Benzodiazepines are a class of pharmaceutical APIs (active pharmaceutical ingredients) widely used in the treatment of various medical conditions. These compounds belong to the family of psychoactive drugs and are primarily known for their anxiolytic (anti-anxiety), sedative, hypnotic, and muscle relaxant properties.
Benzodiazepines work by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain that helps regulate neuronal excitability. By increasing the effects of GABA, benzodiazepines promote relaxation, reduce anxiety, and induce sleep. Due to their effectiveness, benzodiazepines have become a key therapeutic option for treating anxiety disorders, panic attacks, insomnia, seizures, and muscle spasms.
The pharmaceutical industry offers a wide range of benzodiazepine APIs, including well-known compounds like diazepam, lorazepam, alprazolam, and clonazepam. These APIs are typically synthesized through complex chemical processes and must adhere to stringent quality standards to ensure their purity, potency, and safety.
Benzodiazepines are commonly formulated into oral tablets, capsules, or liquids for easy administration. They are available under various brand names and may require a prescription due to their potential for misuse and dependence. The dosage and duration of benzodiazepine treatment should be carefully determined by healthcare professionals to minimize the risk of adverse effects.
It is important to note that benzodiazepines may cause side effects such as drowsiness, dizziness, impaired coordination, and memory problems. Long-term use or sudden discontinuation of benzodiazepines can lead to withdrawal symptoms and should be managed under medical supervision.
In summary, benzodiazepines are a crucial category of pharmaceutical APIs used to alleviate anxiety, induce sleep, and relax muscles. They play a significant role in the treatment of various medical conditions, but their usage requires careful monitoring and adherence to medical guidelines to ensure safe and effective outcomes for patients.
